In summary we describe 107 validated loci for BP offering new biology, identifying potential new therapeutic targets and raising the possibility of a precision medicine approach to modify risk of hypertension and cardiovascular outcomes. Altogether, this represents a major advance in our understanding of the genetic architecture of BP.
